TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia

[1]  K. Kuliczkowski,et al.  The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia , 2016, Archivum Immunologiae et Therapiae Experimentalis.

[2]  K. Stamatopoulos,et al.  B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4 , 2016, The Journal of Immunology.

[3]  T. Haferlach,et al.  Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia. , 2016, Blood.

[4]  A. van den Berg,et al.  Toll-like receptors in the pathogenesis of human B cell malignancies , 2014, Journal of Hematology & Oncology.

[5]  J. Xie,et al.  Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll‐like receptor 2‐mediated cell‐penetrating peptide , 2014, International journal of cancer.

[6]  R. Foà,et al.  Clinical implications of the molecular genetics of chronic lymphocytic leukemia , 2013, Haematologica.

[7]  K. Stamatopoulos,et al.  Immunoglobulin Gene Repertoire in Chronic Lymphocytic Leukemia: Insight into Antigen Selection and Microenvironmental Interactions , 2012, Mediterranean journal of hematology and infectious diseases.

[8]  A. Dmoszyńska,et al.  TLR2 may influence the behavior of the malignant clone in B-CLL. , 2012, Blood cells, molecules & diseases.

[9]  L. Llorente,et al.  Immunological aspects in chronic lymphocytic leukemia (CLL) development , 2012, Annals of Hematology.

[10]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[11]  Stavroula Ntoufa,et al.  Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients , 2011, Haematologica.

[12]  Paolo Ghia,et al.  Expression and function of toll like receptors in chronic lymphocytic leukaemia cells , 2009, British journal of haematology.

[13]  G. Simonetti,et al.  The role of Toll-like receptors in chronic B cell malignancies , 2009, Leukemia & lymphoma.

[14]  K. Stamatopoulos,et al.  Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation , 2008, Journal of internal medicine.

[15]  R. Bataille,et al.  Toll-like receptors: lessons to learn from normal and malignant human B cells. , 2008, Blood.

[16]  D. Rawlings,et al.  B cell autonomous TLR signaling and autoimmunity. , 2008, Autoimmunity reviews.

[17]  Nikolaos Laoutaris,et al.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. , 2007, Blood.

[18]  Yong Zhao,et al.  Toll‐like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells , 2007, Immunology.

[19]  P. Feugier,et al.  Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells , 2007, Haematologica.

[20]  S. Normark,et al.  Role of the innate immune system in host defence against bacterial infections: focus on the Toll‐like receptors , 2007, Journal of internal medicine.

[21]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[22]  J. Roliński,et al.  The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  Terry Hamblin,et al.  Prognostic factors in chronic lymphocytic leukemia , 2006, Leukemia & lymphoma.

[24]  Damo Xu,et al.  Direct and indirect role of Toll-like receptors in T cell mediated immunity. , 2004, Cellular & molecular immunology.

[25]  R. Medzhitov,et al.  Regulation of Phagosome Maturation by Signals from Toll-Like Receptors , 2004, Science.

[26]  M. Netea,et al.  Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells , 2004, The Journal of Immunology.

[27]  S. Akira.  Mammalian Toll-like receptors. , 2003, Current opinion in immunology.

[28]  A Benner,et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[29]  E. Montserrat,et al.  Prognostic factors in chronic lymphocytic leukemia. , 1987, Seminars in hematology.

[30]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.

[31]  I. Cremer,et al.  Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword. , 2017, Immunobiology.